Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm

PHASE3CompletedINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

January 31, 2007

Conditions
Hemifacial Spasm
Interventions
BIOLOGICAL

Botulinum toxin type A

Trial Locations (4)

100730

Neurology Department, Peking Union Medical College Hospital, Beijing

200025

Neurology Department, Shanghai Ruijin Hospital, Shanghai

310016

Neurology Department, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou

510080

Neurology Department, Guangdong Provincial People's Hospital, Guangdong

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY